EISAI TO BEGIN ENROLLING STUDY IN PATIENTS WITH NARCOLEPSY ...Middle East

NUTLEY, N.J., July 8, 2024 /PRNewswire/ -- Eisai Inc. announced today that screening for Study E2086-A001-101 (Study 101) to assess the efficacy, safety and tolerability of E2086, a novel selective orexin-2 receptor, is now registered on ClinicalTrials.gov as NCT06462404. Study sites are...

Hence then, the article about eisai to begin enrolling study in patients with narcolepsy was published today ( Monday 08/07/2024 - 04:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EISAI TO BEGIN ENROLLING STUDY IN PATIENTS WITH NARCOLEPSY )

Also on site :

• ‘Zootopia 3’ Is Officially Happening — and Opening the City to a New Kind of Animal
• Ellie Goulding Sues Former Managers Over Live Nation Deal
• Billboard Ranks the 100 Biggest Hits of the Jackson Family, From Early Janet Jackson to Michael Jackson’s Most Iconic Duets